Wei Shi

6.2k total citations
175 papers, 3.7k citations indexed

About

Wei Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wei Shi has authored 175 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 33 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Wei Shi's work include RNA modifications and cancer (10 papers), DNA Repair Mechanisms (10 papers) and Genomics and Chromatin Dynamics (8 papers). Wei Shi is often cited by papers focused on RNA modifications and cancer (10 papers), DNA Repair Mechanisms (10 papers) and Genomics and Chromatin Dynamics (8 papers). Wei Shi collaborates with scholars based in China, United States and Australia. Wei Shi's co-authors include Steven L. Teitelbaum, F. Patrick Ross, Kanji Yoshida, Chie Watanabe, Xiaosong Wang, Atsushi Kumanogoh, Hitoshi Kikutani, Kum Kum Khanna, Junran Zhang and Sunao Takeshita and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Wei Shi

166 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Shi China 33 1.9k 953 645 524 306 175 3.7k
Liqun Chen China 28 1.4k 0.7× 488 0.5× 544 0.8× 309 0.6× 273 0.9× 69 2.7k
Hua Chen China 30 1.7k 0.9× 876 0.9× 854 1.3× 326 0.6× 153 0.5× 90 3.6k
Xiaomei Yang China 37 2.0k 1.0× 583 0.6× 969 1.5× 323 0.6× 137 0.4× 111 3.6k
Shih‐Wei Wang Taiwan 40 2.2k 1.1× 903 0.9× 935 1.4× 577 1.1× 132 0.4× 201 4.9k
Ovidio Bussolati Italy 39 2.1k 1.1× 808 0.8× 497 0.8× 242 0.5× 310 1.0× 163 4.8k
Ming Zhao China 36 2.6k 1.3× 534 0.6× 476 0.7× 784 1.5× 215 0.7× 170 5.2k
Ke Xu China 38 2.1k 1.1× 792 0.8× 1.1k 1.8× 444 0.8× 215 0.7× 145 4.2k
Ruifang Niu China 38 2.5k 1.3× 969 1.0× 972 1.5× 413 0.8× 103 0.3× 87 3.9k
Aimin Li China 38 2.6k 1.4× 879 0.9× 890 1.4× 553 1.1× 359 1.2× 220 5.1k
Hu Chen China 33 2.0k 1.0× 939 1.0× 953 1.5× 308 0.6× 84 0.3× 176 3.7k

Countries citing papers authored by Wei Shi

Since Specialization
Citations

This map shows the geographic impact of Wei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Shi more than expected).

Fields of papers citing papers by Wei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Shi. The network helps show where Wei Shi may publish in the future.

Co-authorship network of co-authors of Wei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Shi. A scholar is included among the top collaborators of Wei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Shi. Wei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huo, Shengqi, Moran Wang, Min Du, et al.. (2025). Macrophage-derived S100A9 promotes diabetic cardiomyopathy by disturbing mitochondrial quality control via STAT3 activation. International Journal of Biological Sciences. 21(7). 3061–3080. 4 indexed citations
2.
3.
Cai, M., Xiang Hong, Yinan Guo, et al.. (2024). 173P A phase II trial of donafenib plus sintilimab for advanced stage hepatocellular carcinoma. Annals of Oncology. 35. S79–S79. 1 indexed citations
4.
Chen, Menghui, Zhiguo Hou, Yao Qin, et al.. (2024). Pirfenidone in the Treatment of Radiation-Induced Lung Injury: A Randomized, Controlled, Multicenter Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S14–S14. 2 indexed citations
5.
Han, Zongsu, Joshua Rushlow, Yihao Yang, et al.. (2024). Lithium extraction by metal–organic frameworks. Inorganic Chemistry Frontiers. 11(24). 8589–8601. 2 indexed citations
6.
Wang, Chang, Shibo Wang, Wei Shi, et al.. (2024). Solvent‐Assisted Surface Modification Using Metallocene‐Based Molecules for High‐Efficiency Perovskite/Silicon Tandem Solar Cells. Advanced Energy Materials. 14(31). 20 indexed citations
7.
8.
Wang, Yingjie, Guangyan Xu, Yanwei Sun, et al.. (2024). Creating Atomically Iridium-Doped PdOx Nanoparticles for Efficient and Durable Methane Abatement. Environmental Science & Technology. 58(23). 10357–10367. 14 indexed citations
9.
Shen, Wei, Lun Li, Wei Shi, et al.. (2023). Characteristic chromanone acids from Calophyllum membranaceum: Determination of C-3 configuration and anti-inflammatory activity. Phytochemistry. 217. 113902–113902. 2 indexed citations
10.
11.
Bitar, Mainá, S. Rivera, Wei Shi, et al.. (2023). Redefining normal breast cell populations using long noncoding RNAs. Nucleic Acids Research. 51(12). 6389–6410. 4 indexed citations
12.
Shi, Wei, et al.. (2023). Study on the Temporal and Spatial Evolution of China’s Carbon Dioxide Emissions and Its Emission Reduction Path. Energies. 16(2). 829–829. 5 indexed citations
13.
Yu, Chunping, Hong Zhang, Shuangxin Liu, et al.. (2022). Flot2 acts as a novel mediator of podocyte injury in proteinuric kidney disease. International Journal of Biological Sciences. 19(2). 502–520. 6 indexed citations
14.
Shao, Jia, Linlin Xu, Limin Chen, et al.. (2017). Arl13b Promotes Gastric Tumorigenesis by Regulating Smo Trafficking and Activation of the Hedgehog Signaling Pathway. Cancer Research. 77(15). 4000–4013. 34 indexed citations
15.
Pandita, Raj K., Tracy T. Chow, Durga Udayakumar, et al.. (2015). Single-Strand DNA-Binding Protein SSB1 Facilitates TERT Recruitment to Telomeres and Maintains Telomere G-Overhangs. Cancer Research. 75(5). 858–869. 14 indexed citations
16.
Boucher, Didier, Therese Vu, Amanda L. Bain, et al.. (2015). Ssb2/Nabp1 is dispensable for thymic maturation, male fertility, and DNA repair in mice. The FASEB Journal. 29(8). 3326–3334. 13 indexed citations
17.
Al‐Ejeh, Fares, Marina Pajic, Wei Shi, et al.. (2014). Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 20(12). 3187–3197. 31 indexed citations
18.
Shi, Wei, et al.. (2011). A RESEARCH OF PREPARING ENVIRONMENTAL FRIENDLY RUBBER PROCESSING OIL BY EXTRACTION. 42(4). 70. 2 indexed citations
19.
Shi, Wei. (2009). Optimum Hydraulic Design and Model Test for Elbow Inlet Passage. Fluid Machinery. 1 indexed citations
20.
Yang, Xia, et al.. (2008). Recovery of Rare Earth from Spent MH- Ni Battery Negative Electrode. 28(1). 70–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liqun Chen Breakdown of academic impact, for papers by Hua Chen Breakdown of academic impact, for papers by Xiaomei Yang Breakdown of academic impact, for papers by Shih‐Wei Wang Breakdown of academic impact, for papers by Ovidio Bussolati Breakdown of academic impact, for papers by Ming Zhao Breakdown of academic impact, for papers by Ke Xu Breakdown of academic impact, for papers by Ruifang Niu Breakdown of academic impact, for papers by Aimin Li Breakdown of academic impact, for papers by Hu Chen
Rankless by CCL
2026